Brief: Firebrick Pharma Signs Agreement To Market Nasodine To Healthcare Professionals In Singapore
31/10/2024 01:31
Oct 31 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* AGREEMENT SIGNED TO MARKET NASODINE TO HEALTHCARE
PROFESSIONALS
IN SINGAPORE
Source text: ID:nASXcc2f83
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement